These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29977013)
1. NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Dasgupta S; Aly AM; Malloy MH; Okorodudu AO; Jain SK J Perinatol; 2018 Sep; 38(9):1252-1257. PubMed ID: 29977013 [TBL] [Abstract][Full Text] [Related]
2. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus. Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349 [TBL] [Abstract][Full Text] [Related]
3. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants. Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654 [TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review. Xiong T; Kulkarni M; Gokulakrishnan G; Shivanna B; Pammi M J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319 [TBL] [Abstract][Full Text] [Related]
6. Association of BNP, NTproBNP, and early postnatal pulmonary hypertension in very preterm infants. König K; Guy KJ; Walsh G; Drew SM; Barfield CP Pediatr Pulmonol; 2016 Aug; 51(8):820-4. PubMed ID: 26969913 [TBL] [Abstract][Full Text] [Related]
7. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life. Fritz AS; Keller T; Kribs A; Hünseler C Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of Brain Natriuretic Peptide for Diagnosing Pulmonary Hypertension in Severe Bronchopulmonary Dysplasia. Avitabile CM; Ansems S; Wang Y; Fraga MV; Kirpalani HM; Zhang H; Mercer-Rosa L; Jensen EA Neonatology; 2019; 116(2):147-153. PubMed ID: 31096210 [TBL] [Abstract][Full Text] [Related]
9. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study. Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673 [TBL] [Abstract][Full Text] [Related]
10. BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia. König K; Guy KJ; Nold-Petry CA; Barfield CP; Walsh G; Drew SM; Veldman A; Nold MF; Casalaz DM Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1076-L1081. PubMed ID: 27760764 [TBL] [Abstract][Full Text] [Related]
11. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study. Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045 [TBL] [Abstract][Full Text] [Related]
12. Screening Echocardiography and Brain Natriuretic Peptide Levels Predict Late Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia. Behere S; Alapati D; McCulloch MA Pediatr Cardiol; 2019 Jun; 40(5):973-979. PubMed ID: 30937503 [TBL] [Abstract][Full Text] [Related]
14. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants]. Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715 [No Abstract] [Full Text] [Related]
15. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769 [TBL] [Abstract][Full Text] [Related]
16. Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study. Naeem B; Ayub A; Aly AM; Malloy MH; Okorodudu AO; Jain SK J Perinatol; 2020 Apr; 40(4):628-632. PubMed ID: 31911650 [TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity? Kalra VK; Aggarwal S; Arora P; Natarajan G Pediatr Pulmonol; 2014 Nov; 49(11):1106-11. PubMed ID: 24214578 [TBL] [Abstract][Full Text] [Related]
18. [Establishment and efficiency test of a clinical prediction model of bronchopulmonary dysplasia associated pulmonary hypertension in very premature infants]. Cao JK; Fan HQ; Xiao YB; Wang D; Liu CG; Peng XM; Gao XR; Tang SH; Han T; Mei YB; Liang HY; Wang SM; Wang F; Li QP Zhonghua Er Ke Za Zhi; 2024 Feb; 62(2):129-137. PubMed ID: 38264812 [No Abstract] [Full Text] [Related]
19. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants. Khan S; Concina VA; Schneider D; Westgate P; Arriagada S; Bada H Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001 [TBL] [Abstract][Full Text] [Related]
20. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]